Clinical Trial Update: ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of oxaliplatin (ZD0473) in patients with progressive or relapsed non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Oxaliplatin (Eloxatin) (oxaliplatin)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN